Accèder directement au contenu

SignalMed+

SignalMed+ is a MedTech company, cofounded by Prs Nathalie Kubis and David Holcman in 2022, emerging from ENS-PSL University and APHP, pionered in predicting brain states using real-time EEG signal processing.

"SignalMed+ is a startup specializing in the development of intelligent algorithms to monitor and predict brain states, primarily focusing on medical care and prevention. The company aims to optimize anesthesia control and predict outcomes for various types of comas using advanced EEG signal processing, computational neuroscience modeling, artificial intelligence, and classification methods. This technology aims to prevent excessively deep or too lower anesthesia and provide personalized dosage recommendations, particularly benefiting sensitive patient groups such as children and the elderly"

100 Start-up to invest in 2024